DOCSLIB.ORG

Non-Drowsy Sinutab

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Non-Drowsy Sinutab Project Name / Design Non-Drowsy Sinutab Tablets 15s – 1 – 12 mm New Component / Item Code 360164C ArtWorks ID EMEA_2020_00005102_001 If any of these apply to you, get advice from Old Component / Item Code 360164B Languages English a doctor or pharmacist without using Non-Drowsy Sinutab. Product / Eurocode / Mat. ID Code 8166703 Job / Version No. 402061024_r1 Date 17-02-2021 paracetamol, pseudoephedrine Talk to your doctor or pharmacist… n If you have kidney or severe liver problems. CHILD n This medicine is used to relieve the symptoms of n If you have alcohol dependence. Black PANTONE Reflex Blue C colds, flu and allergies including aches, pains, n If you have blocked arteries or veins fever, nasal and sinus congestion. (occlusive vascular disease). LITHO OFFSET LITHO OFFSET n This medicine is for use by adults and children n REPRESENTATION: Colours represented with a diagonal line have been modified to aid PDF approval. If you are being treated for a thyroid aged 12 years and over. disorder. n Do not take this medicine: n If you have difficulty with passing water F_I_006 PC-0002781 n There are some people who should not take and / or an enlarged prostate (which may this medicine. To find out if you are one of mean you need to pass water more often). PAPER Westrock St Pierre des Corps them see section 2 ▶ n If you are taking any other medicines, 1003 n If you have ever had a bad reaction to any of including: the ingredients. For the list of ingredients see n Anticholinergic drugs (drugs used to treat section 6 ▶ cramps and spasms such as atropine). Leaflet Val De Reuil n Speak to your doctor: n Antihypertensives (drugs to treat high 145 x 250 mm JJSC_00023_V2 11-09-2020 n If you suffer from any of the conditions blood pressure such as guanethidine, mentioned in section 2. See section 2 ▶ methyldopa, adrenergic neurone blockers, n If you are taking any other medicines. See debrisoquine, bretylium and betanidine). section 2 ▶ n Tricyclic antidepressants (used to treat n Follow the dosage instructions carefully. See mood disorders). section 3 ▶ n Moclobemide (used to treat mood Now read this whole leaflet carefully before you disorders). use this medicine. Keep the leaflet: you might n Cardiac glycosides (drugs used to control need it again. heart rhythms or contractions such as digoxin). 1 What the medicine is for n Ergot alkaloids (drugs used to treat Non-Drowsy Sinutab relieves the symptoms of migraine such as ergotamine and colds, flu and allergies including aches, pains, methysergide). fever, nasal and sinus congestion. The tablets n Oxytocin (drug used to help contractions contain paracetamol, an analgesic and antipyretic during childbirth). to relieve pain and fever, and pseudoephedrine, a n Cholestyramine (used to lower blood decongestant to clear nasal congestion and blocked cholesterol). Helvetica World-Regular sinuses. n Metoclopramide and domperidone (used NimbusSansGlobal-Regular 5.0pt This medicine is for use in adults and children aged to treat nausea and vomiting). Times New Roman-Bold 12 years and over. n Anticoagulants (drugs used to thin the Times New Roman-Italic blood such as warfarin). 250 mm 8.0pt Times New Roman-Regular 2 Before taking this n Oral contraceptives ("the pill"). Zapf Dingbats-Regular n Anticonvulsants (drugs used to treat 14.0pt medicine epilepsy). This medicine is suitable for most people but a few If you are not sure about any of the medicines people should not use it. If you are in any doubt, you are taking, show the bottle or pack to talk to your doctor or pharmacist. your pharmacist. Do not use this medicine… If any of these bullet points apply to you now n If you have ever had a bad reaction to any or in the past, talk to a doctor or of the ingredients in this medicine (listed in pharmacist. section 6). If you experience the following, stop taking n If you have high blood pressure or heart this medicine immediately and contact your disease. doctor: n If you have diabetes. n A feverish generalised redness of the skin n If you have a phaeochromocytoma (a rare (erythema) associated with pustules. See tumour that affects your heart rate and section 4. blood pressure). n Sudden severe headaches, nausea, vomiting, n If you have an overactive thyroid gland. confusion, fits, visual disturbances. n If you have glaucoma (increased pressure n Sudden abdominal pain or rectal bleeding in the eye). may occur with this medicine, due to n If you have severe kidney problems. inflammation of the colon (ischaemic 1 12 1 n If you are taking any other cough and cold colitis). If you develop these gastrointestinal medicines or medicines containing symptoms, stop taking this medicine and paracetamol. contact your doctor or seek medical 2 n If you are taking beta blockers (used to treat attention immediately. See section 4. high blood pressure). n Reduction of blood flow to your optic nerve n If you are taking, or have taken in the last may occur with this medicine. If you develop two weeks, drugs for depression known as sudden loss of vision, stop taking this Monoamine Oxidase Inhibitors (MAOIs) or medicine and contact your doctor or seek Reversible Inhibitors of Monoamine medical attention immediately. See section 4. Oxidase (RIMAs). If you are pregnant or breast-feeding n If you are taking stimulants or appetite n If you are pregnant, or breast-feeding, think suppressants or drugs used to treat you may be pregnant or are planning to congestion and asthma (sympathomimetic have a baby, ask your doctor or pharmacist drugs). for advice before taking this n For children under 12 years old. medicine. turn over ▶ 12 mm 14 mm 12 mm 145 mm PAGE 2 – 2 – 12 mm n Trouble passing water (especially in men with 3 How to take this prostate problems). medicine Other effects which may occur include: Check the table that follows to see how much Very Common (may affect more than medicine to take. 1 in 10 people) n For oral use only. n Headache n Do not take more medicine than the label tells Common (may affect up to 1 in 10 you to. people) n Take with a glass of water. n Difficulty sleeping, nervousness or dizziness Children under 12 years n Dry mouth or nausea Do not give to children under 12 years old. Other effects which may occur but it is unknown Adults and children aged 12 years and over how often n Anxiety, restlessness, irritability, feeling jittery or Age Dose feelings of extreme happiness n Adults and children 2 tablets every 4-6 Sleep disturbances n aged 16 years and hours, up to 4 times a A fast or irregular heartbeat or an increased over day awareness of the heartbeat (palpitations) n Drowsiness Children aged 12 1 tablet every 4-6 n High blood pressure years to 15 years hours, up to 4 times a n Stomach pain, diarrhoea or vomiting day n Pain when passing water n Tingling or numbness of the hands or feet (pins n Leave at least 4 hours between doses. and needles) n Do not take more than 4 doses in 24 hours. n A tremor or shakiness n If symptoms persist or worsen, stop use and n Reduced blood flow to the optic nerve talk to your doctor. (Ischaemic optic neuropathy) Very rare cases of serious skin reactions have been If anyone has too much reported with paracetamol. Talk to a doctor at once if you take too much Reporting of side effects of this medicine even if you feel well. This is If you get any side-effects, talk to your doctor, because too much paracetamol can cause pharmacist or nurse. This includes any possible delayed, serious liver damage. side-effects not listed in this leaflet. You can also If you forget to take the medicine report side-effects directly via the Yellow Card If you forget to take a dose, take the next dose Scheme at www.mhra.gov.uk/yellowcard or search when needed provided that the last dose was for MHRA Yellow Card in the Google Play or taken at least 4 hours ago. Do not take a Apple App Store. double dose. By reporting side-effects, you can help provide more information on the safety of this medicine. 4 Possible side-effects 250 mm Like all medicines, Non-Drowsy Sinutab can have 5 Storing this medicine side-effects, although not everybody gets them. Do not store above 25ºC. If you experience any of the following, stop using Store in the original packaging. this medicine and seek immediate medical help: Keep this medicine out of the sight and reach of n Reduced blood flow to the heart which can cause children. angina (discomfort or pain in the chest, neck, Do not use this medicine after the expiry date back, jaw, shoulders or arms), or heart attack. which is stated on the carton after ‘Expiry’. The n Stroke (weakness of the face, arms or legs, or expiry date refers to the last day of that month. speech problems). Medicines should not be disposed of via n Sudden onset of fever, reddening of the skin, wastewater or household waste. Ask your or many small pustules (possible symptoms of pharmacist how to dispose of medicines no longer Acute Generalized Exanthematous Pustulosis required. These measures will help to protect the - AGEP) may occur within the first 2 days of environment. treatment with this medicine (See section 2). n Sudden onset of severe headache, nausea, 6 Further information vomiting, confusion, fits, visual disturbances. What's in this medicine? n Swelling of the face, lips, mouth, tongue or The active ingredients in Non-Drowsy Sinutab throat which may cause difficulty in swallowing are: 500 mg Paracetamol and 30 mg or breathing.
Load more

Recommended publications
  • No. 33981 2 No
    Pretoria, 4 February 2011 Februarle No. 33981 2 No. 33981 GOVERNMENT GAZETTE, 4 FEBRUARY 2011 IMPORTANT NOTICE The Government Printing Works will not be held responsible for faxed documents not received due to errors on the fax machine or faxes received which are unclear or incomplete. Please be advised that an "OK" slip, received from a fax machine, will not be accepted as proof that documents were received by the GPW for printing. If documents are faxed to the GPW it will be the sender's respon­ sibility to phone and confirm that the documents were received in good order. Furthermore the Government Printing Works will also not be held responsible for cancellations and amendments which have not been done on original documents received from clients. CONTENTS INHOUD Bladsy Koerant Page Gazette No. No. No. No. No. No. GENERAL NOTICE ALGEMENEKENNISGEWING Health, Department of Gesondheld, Departement van General Notice A/gemene Kennisgewing 58 Medicines and Related Substances Act 58 Wet op Beheer van Medisyne en (101/1965): Medicines Control Council: Verwante Stowwe (101/1965): Conditions of registration of a medicine Medisynebeheerraad: Voorwaardes vir in terms of the provisions of section die registrasie van 'n medisyne in terme 15 (7) ..................................................... .. 3 33981 van die bepalings van artikel 15 (7) ........ 4 33981 STAATSKOERANT, 4 FEBRUARIE 2011 No. 33981 3 GENERAL NOTICE ALGEMENE KENNISGEWING NOTICE 58 OF 2011 MEDICINES CONTROL COUNCIL CONDITIONS OF REGISTRATION OF A MEDICINE IN TERMS OF THE PROVISIONS OF SECTION 15(7) OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 1. The applicant shall ensure that the medicine is manufactured and controlled in terms of the current Good Manufacturing Practices as determined by Council 2.
    [Show full text]
  • Mcneil Consumer : Mdl No
    IN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF PENNSYLVANIA IN RE: MCNEIL CONSUMER : MDL NO. 2190 HEALTHCARE, ET AL., MARKETING : AND SALES PRACTICES LITIGATION : : Applies to: : ALL ACTIONS : MEMORANDUM McLaughlin, J. July 13, 2012 This multidistrict litigation arises out of quality control problems at the defendants’ facility manufacturing over- the-counter healthcare products in Fort Washington, Pennsylvania, which led to a series of recalls of those products. The named plaintiffs assert claims for economic loss on behalf of a putative nationwide class against Johnson & Johnson (“J&J”), McNeil Consumer Healthcare (“McNeil”), and four of their executives. The plaintiffs allege that they overpaid for the defendants’ products as a result of the recalls and the defendants’ scheme to conceal or downplay the scope of the quality control problems. The defendants, who have offered a coupon or cash refund to consumers who purchased recalled drugs, have moved to dismiss the operative complaint, and assert that the named plaintiffs lack constitutional standing and have not met the applicable pleading standard. The Court will grant the defendants’ motion because the plaintiffs have not pled facts that show a cognizable injury in fact, which is required to confer Article III standing. I. Procedural Background This litigation resulted from the consolidation of ten individual actions filed around the country. Haviland v. McNeil Consumer Healthcare, No. 10-2195, was filed in this Court on May 12, 2010, asserting economic injuries arising out of the April 30, 2010 recall of over-the-counter children’s drugs by McNeil, a part of the J&J “Family of Companies.” Eight additional cases, also arising out of the April 2010 recall, were filed in district courts around the country.1 All cases asserted claims for economic injury only, with the exception of Rivera v.
    [Show full text]
  • Notice Under S66 of the Commerce Act 1986 Application by Johnson & Johnson to Acquire the Stock, Assets and Business Of
    PUBLIC COPY Notice under s66 of the Commerce Act 1986 Application by Johnson & Johnson to acquire the stock, assets and business of the Consumer Healthcare division of Pfizer Inc. COMMERCE ACT 1986: BUSINESS ACQUISITION SECTION 66: NOTICE SEEKING CLEARANCE 28 September 2006 The Registrar Business Acquisitions and Authorisations Commerce Commission PO Box 2351 Wellington Pursuant to s66(1) of the Commerce Act 1986 notice is hereby given seeking clearance of a proposed business acquisition. 518689_1.DOC 2 CONTENTS EXECUTIVE SUMMARY PART 1: TRANSACTION DETAILS 1 The business acquisition for which clearance is sought 2 The person giving this notice 3 Confidentiality 4 Participants 5 Interconnected and associated persons 6 Beneficial interests 7 Links between participants 8 Common directorships 9 Business activities of the participants 10 Reasons for the proposed acquisition PART II: IDENTIFICATION OF MARKETS AFFECTED 11 Horizontal aggregation 12 Differentiated product markets 13 Differentiated product markets 14 Vertical integration 15 Other business acquisitions PARTS III, IV AND V: CONSTRAINTS ON MARKET POWERS BY EXISTING AND POTENTIAL COMPETITION AND OTHER POTENTIAL CONSTRAINTS 16 Allergy medication 17 Products for the treatment of worms 18 Thrush treatment CERTIFICATE APPENDICES 1. Heartburn and indigestion remedies (MYLANTA and MOTILIUM) 2. Worm treatments (COMBANTRIN, VERMOX) 3. Cold, flu, nasal decongestant, cough relief and sort throat medications (CODRAL, SINUTAB, SUDAFED, BENADRYL, BRONDECON) 4. Allergy relief products (ACTIFED, SINUTAB, SUDAFED, VISINE, LIVOSTIN) 518689_1.DOC 3 5. Thrush treatments (DIFLUCAN ONE, DAKTARIN, DAKTAGOLD, NIZORAL, SPORANOX) 6. Shampoo (PREGAINE, ROGAINE, NEUTROGENA, JOHNSON’S BABY SHAMPOO) 7. Hand hygiene (PURELL and MICRO SHIELD) 8. Competitor worm treatment products 9. Multinational pharmaceutical businesses: GlaxoSmithKline, Douglas Pharmaceuticals, Alphapharm, Bayer Group 10.
    [Show full text]
  • Medication Code Key: PMCODE and Drug Name in 2007 NHHCS Cdc-Pdf
    Medication Code Key: PMCODE and Drug Name in 2007 NHHCS PMCODE Drug Name 00002 TAMIFLU 00003 DITROPAN XL II 00004 LIDODERM PATCH 00008 VIACTIV 00010 A AND D II 00013 MYCOPHENOLATE MOFETIL 00017 SIROLIMUS 00019 HAWTHORN 00027 SYNAGIS 00032 EXCEDRIN MIGRAINE 00036 MAALOX PLUS 00037 ACEON 00038 GLYSET 00039 SONATA 00042 PROTONIX 00044 PANLOR DC 00048 MOBIC 00052 SILDENAFIL CITRATE 00053 TAMSULOSIN HYDROCHLORIDE 00054 COMTAN 00058 MINERAL SUPPLEMENT 00061 BISMUTH 00071 CERTAVITE 00073 LUXIQ 00075 SAL-TROPINE 00076 TRILEPTAL 00078 AGGRENOX 00080 CARBIDOPA-LEVODOPA 00081 EXELON 00084 PREGABALIN 00085 ORAMORPH 00096 OSTEO-BIFLEX 00099 ALOCRIL 00100 A.S.A. 00101 ISOSORBIDE DINITRATE 00102 ISOSORBIDE MONONITRATE 00107 ROSIGLITAZONE MALEATE 00109 URSODIOL 00112 MEDERMA 00113 ANDROGEL 00114 DILTIA XT 00117 CRANBERRY 00123 NICOTINE 00125 AVELOX 00132 CAL-MAG 00133 CANDESARTAN Page 1 Medication Code Key: PMCODE and Drug Name in 2007 NHHCS PMCODE Drug Name 00148 PROLIXIN D 00149 D51/2 NS 00150 NICODERM CQ PATCH 00151 TUSSIN 00152 CEREZYME 00154 CHILDREN'S IBUPROFEN 00156 PROPOXACET-N 00159 KALETRA 00161 BISOPROLOL 00167 NOVOLIN N 00169 KETOROLAC TROMETHAMINE 00172 OPHTHALMIC OINTMENT 00173 ELA-MAX 00176 PREDNISOLONE ACETATE 00179 COLLOID SILVER 00184 KEPPRA 00187 OPHTHALMIC DROPS 00190 ABDEC 00191 HAPONAL 00192 SPECTRAVITE 00198 ENOXAPARIN SODIUM 00206 ACTONEL 00208 CELECOXIB 00209 GLUCOVANCE 00211 LEVALL 5.0 00213 PANTOPRAZOLE SODIUM 00217 TEMODAR 00218 CARBAMIDE PEROXIDE 00221 CHINESE HERBAL MEDS 00224 MILK AND MOLASSES ENEMA 00238 ZOLMITRIPTAN 00239
    [Show full text]
  • Procedure Description Charge Amount 0302000014 ROOM MED
    Charge Procedure Description Amount 0302000014 ROOM MED SURG MOSU 1,040.00 0302000015 ROOM MED SURG PEDS 3,500.00 0302000033 OUT PATIENT BED MOSU 0.00 0302000035 ROOM INTERMEDIATE MOSU 2,055.00 0302000043 ROOM HOSPICE MOSU 805.00 0302000045 ROOM MED SURG W TELE MOSU 1,530.00 0302000050 OBSERVATION INTERM PER HR MOSU 97.00 0302002283 FECAL MANAGEMENT SYSTEM 694.00 0302010232 CATH INDWELL BLADDER SIMPLE 185.00 0302010304 OBSERVATION MS PER HR MOSU 60.00 0302010305 OBSERVATION TELE PER HR MOSU 71.00 0302010556 NONBILLABLE OBSERVATION HR 0.00 0302010557 OBSERVATION DIRECT ADM MOSU 130.00 0302020287 SUPPLIES CHEST TUBE 228.00 0302050318 LUMBAR PUNCTURE DIAGNOSTIC 1,035.00 0302050451 IV INF THERAPEUTIC EA ADD HR 170.00 0302050453 IV INF THERAPEUTIC UP TO 1HR 635.00 0302050454 IRRIGATION BLADDER 780.00 0302050480 INSERT VENOUS CENTRAL LINE 1,315.00 0302050490 IV PUSH INITIAL DRUG 380.00 0302050534 I&D ABSCESS SIMPLE 675.00 0302050603 IV PUSH EA SEQUENTIAL DRUG 153.00 0302050648 HEMODIALYSIS SERVICE IP 1,455.00 0302050813 ARTHROCENTESIS MAJ JNT WO IMAG 630.00 0302050885 ADMIN IMMUNIZATION 145.00 0302050948 DIALYSIS INTRAPERITONEAL SERV 655.00 0302060002 INJECTION SUB-Q/IM 155.00 0302060008 CHEMO ADMIN IV INF EA ADD HR 410.00 0302060101 HEMODIALYSIS SERVICE OBS/OP 1,455.00 0302060269 US PV RESIDUAL URINE 240.00 0302060274 IV PUSH EA ADD DRUG 168.00 0302060275 IV INF CONCURRENT THERAPEUTIC 385.00 0302060276 IV INF SEQUENTIAL THER UP TO 1 191.00 0302060293 INSERT STRAIGHT CATH THERAPEUT 185.00 0302060372 CHEMO ADMIN IV INF SEQ 1 HR 525.00 0302060373
    [Show full text]
  • TITLE Safety and Efficacy of Over-The-Counter Drug Use by the Elderly
    " DOCUMENT RESUME ED 245 148 CG 017 518 TITLE Safety and Efficacy of Over-the-Counter Drug Use by the Elderly. Hearing before the Subcommittee on Health and Long-Term Care of the Select Committee on Aging. House of Representatives, Ninety-Eighth Congress, First Session. INSTITUTION Congress of the U.S., Washington, D.C. House Select Committee on Aging. REPORT NO House-Comm-Pub-98-409 PUB DATE 21 Jul 83 NOTE 507p.; Some pages are marginally legible due to small print. PUB TYPE Legal/Legislative/Regulatory Materials (090) EDRS PRICE MF02 Plus Postage. PC Not Available from EDRS. DESCRIPTORS *Consumer Protection; Dietetics; Drug Legislation; *Drug Use; Gerontology; Hearings; *Older Adults; Physical Health; *Safety IDENTIFIERS Congress 98th; Long Term Care; *Nonprescription Drugs; *PPA ABSTRACT This document contains the prepared statements and panel testimony from the Congressional hearing on over-the-counter (OTC) drug use by the elderly. Opening statements are given by Representatives Claude Pepper (chairman), Ralph Regula, Mary Rose Oakar, Michael Bilirakis, Tom Lantos, and Hal Daub. Topics which are covered include the incidence and quantity of drug use by the elderly, health risks, adverse reactions, phenylpropanolamine (PPA), consumer protection, and the Federal Drug Administration's (FDA) role in the OTC drug safety and reguIatiem. Testimony of the first panel on OTC drugs, particularly weight reduction medications containing PPA, is given by representatives of the Health Research Group, the National Broadcasting Company, and consumers. Testimony of the second panel on mail fraud schemes perpetrated against senior citizens is given by consumer advocates representing the United States Postal Service, Criminal Investigations and Consumer Protection Divisions, and the Center for Science in the Public Interest.
    [Show full text]
  • Otc) Benefit Medication Formulary
    OVER-THE-COUNTER (OTC) BENEFIT MEDICATION FORMULARY The OTC formulary is a list of medicines (Schedule 0-3) that will be paid from the OTC benefit, subject to the limit specified by the scheme. Metropolitan Generic Reference Price (METREF) will apply. Co-payments will apply for items amounting to more than the reference price. The formulary is subject to regular review. Metropolitan Health reserves the right to update and change the formulary when new information becomes available. IMPORTANT: Please note that the medication on this list is published on an annual basis. Medication and prices are subject to change based on new clinical information and/or pricing updates which may not be reflected on the list below. Product name Active Ingredient Strength Dosage form Schedule Nappi code Oral antiseptics and sore throat Andolex C Benzydamide SPR 1 710149 Andolex Oral Rinse Benzydamide . MOW 1 810576 Andolex Spray Benzydamide . SPR 1 816167 Betadine oral Povidone-iodine MOW 0 707937 Dermadine oral garg Povidone-iodine 1g/100ml MOW 0 799688 Iodised throat Antiseptics LOZ 1 892670 Iodised throat Antiseptics LOZ 1 810010 Medi-keel A Cetylpyridinium LOZ 1 741035 Medi-Keel A black currant Cetylpyridinium LOZ 1 884233 Medi-Keel A honey & lemon Cetylpyridinium LOZ 1 884225 Podine mouth wash Povidone-iodine MOW 0 785210 Septadine oral antiseptic Povidone-iodine MOW 0 819859 Steridine mouthwash and gargle liquid Povidone-iodine MOW 0 890365 Tcp antiseptic Antiseptics SLN 1 815950 Throflam Benzydamide MOW 1 712171 Throflam Benzydamine 22.5mg/15ml
    [Show full text]
  • Laws of Trinidad and Tobago Ministry of Legal Affairs
    LAWS OF TRINIDAD AND TOBAGO MINISTRY OF LEGAL AFFAIRS www.legalaffairs.gov.tt FOOD AND DRUGS ACT CHAPTER 30:01 Act 8 of 1960 Amended by 39 of 1968 156/1972 *31 of 1980 16 of 1986 12 of 1987 6 of 1993 16 of 1998 6 of 2005 *See Note on Validation at page 2 Current Authorised Pages Pages Authorised (inclusive) by L.R.O. 1–2 .. 3–20 .. 21–245 .. UNOFFICIAL VERSION L.R.O. UPDATED TO DECEMBER 31ST 2014 LAWS OF TRINIDAD AND TOBAGO MINISTRY OF LEGAL AFFAIRS www.legalaffairs.gov.tt 2 Chap. 30:01 Food and Drugs Index of Subsidiary Legislation Page Food and Drugs Regulations (GN 130/1964) … … … … 25 Official Method Notification (GN 54/1972) … … … … 124 *Approval of New Drugs Notification … … … … … 129 †Withdrawal of Approval of New Drugs Notification (GN 51/1969) … … 200 Fish and Fishery Products Regulations (LN 220/1998)…………201 †This Notification (i.e. 51/1969) has been amended by LNs 99 and 114/1984 which have been omitted. *Note on Approval of New Drugs Notification The list of new drugs set out in the Schedule to this Notification has been consolidated as at 31st December 1977. This list is so voluminous and changes to it so frequent that, especially in view of its very limited use by the general public, it is not practicable to update it annually. The references to the amendments to this list since 31st December 1977 are contained in the Current Consolidated Index of Acts and Subsidiary Legislation. †Note on Withdrawal of Approval of New Drugs Notification For references to the Withdrawal of Approval of New Drugs Notifications subsequent to the year 1969 — See the current Consolidated Index of Acts and Subsidiary Legislation.
    [Show full text]
  • Allergy Testing
    Randy Taylor, M.D., Ph.D. Jeffrey Chain, M.D. Carol J. Langdoc, M.D. Laurie Burns, MSN, FNP-C Allergy Testing Preparation: It has been recommended that you undergo Allergy Skin testing to further evaluate your condition and see if it could possibly be attributed to allergies. For testing you may need to be off certain prescription and/or over the counter medications. Please review the list of medications that you need to avoid, as well as the time frame that you need to be off of them prior to testing. If these medications are not stopped, we will not be able to perform your test. Contact us if you have any questions. How to Prepare For Testing: Testing may take up to an hour and a half. Please make sure you have allowed for this time for testing to be thorough and safe. Please make sure you have eaten prior to coming in for your testing appointment. Wear a short sleeve/sleeveless loose-fitting top that allow access to the skin of both your arms up to the shoulders. Please be sure to let us know of any tattoos you may have as well so that we can test around them accordingly. Following your testing you will need to make a follow-up appointment with one of our physicians to go over the results. Randy Taylor, M.D., Ph.D. Jeffrey Chain, M.D. Carol J. Langdoc, M.D. Laurie Burns, MSN, FNP-C Allergy Testing What are Allergies? An allergic reaction is a series of events that occur in your immune system.
    [Show full text]
  • Inside This Issue
    Issue No. 225 FDA Counting on Global Strategy April 2011 To Better Secure Supply Chain The FDA’s work toward tighter supply chain control through INsIde thIs Issue international regulatory cooperation is falling short, but a new global strategy may speed up the agency’s progress, a top FDA Sterility issues lead to an- official says. other J&J recall ........Page 2 The next several years are critical in the agency’s transformation FDA zeroes in on compli- to a “global agency,” John Taylor, the FDA’s acting principal deputy ance history to make in- commissioner, said March 14 at a Pew Charitable Trusts conference spection decisions ....Page 3 in Washington, D.C., on drug supply safety. To achieve adequate supply chain control, Taylor said, the FDA 483 Insider ..............Page 5 needs novel and updated enforcement tools, a global alliance of reg- ulators, new authorities to create proactive tools for product safety, APP recalls oncologic irino- tecan over fungal contami- (See Global, Page 2) nation .......................Page 6 McNeil Gets Consent Decree After Pharma manufacturing in Period of Manufacturing Woes Japan largely spared by The FDA has said enough is enough to McNeil Consumer Health- quake ........................Page 8 care over its repeated manufacturing problems, issuing a consent decree that indefinitely closes one plant and places oversight over two others. Bill would increase penal- ties for prescription drug The agency said the Johnson & Johnson subsidiary, which has thefts ......................Page 10 been plagued with recalls of its OTC drugs relating to cGMP viola- tions, will not be able to reopen its troubled Fort Washington, Pa., Dakota labs gets warning plant until a litany of changes have been made.
    [Show full text]
  • Latest List of Pharmacy Only Medicinal Products Not Subject to Medical Prescription This List Was Last Updated on Thursday, September 23, 2021
    Latest list of pharmacy only medicinal products not subject to medical prescription This list was last updated on Thursday, September 23, 2021 Please Note The contents of the table are believed to be correct at the time of compilation. The HPRA makes no representations or warranties about and disclaim all liability for the content, accuracy, completeness or suitability of the information contained in the table for any purpose whatsoever and the information is made available to the public for information purposes only. For any conditions associated with this general sale classification please refer to the detailed product information on the Human Medicines Product listing on the HPRA website. Please note that at time of print some products listed below may not be currently marketed. Part 1. Latest list of pharmacy only medicinal products not subject to medical prescription Trade Name Licence Holder Licence Strength Dosage Form Active Number Ingredients A.Vogel Uva-ursi & A. Vogel Ireland TR2309/021/001 . Oral drops, solution Echinacea Cystitis Ltd, oral drops Abidec Multivitamin Chefaro Ireland PA1186/001/001 25 millilitre(s) Oral drops, solution -Vitamin a palmitate Oral Drops Solution DAC -Ergocalciferolci -Thiamine hydrochloride -Riboflavin sodium phosphate -Pyridoxine hydrochloride -Nicotinamide -Ascorbic acid Acic 5% Cream Rowex Ltd PA0711/017/001 5 percent Cream -ACICLOVIR Acidex Oral Pinewood PA0281/075/001 500mg+267mg+16 Oral suspension -Sodium alginate SuspensionSodium Laboratories Ltd, 0 milligram/ 10 -Sodium Alginate millilitre bicarbonate 500mg,Sodium -Calcium carbonate Bicarbonate 267mg,Calcium Carbonate 160mg/10ml Acnecide 5% w/w Galderma PA22743/001/001 5 percent Gel -Benzoyl peroxide Gel International S.A.S.
    [Show full text]
  • January 21, 1985 C CONGRATULATIONS! Lb the Winners of the Fall 1984 Ford Bronco II Volleyball Classic
    Jamas Madison University Monday, January 21, 1986 Vol. 62 No.27 Baliles: Discusses views concerning campus issues is the checking of identification when By Bill Goodykoontz alcoholic beverages are bought. news editor "The means (of enforcement) won't change. It will simply be a higher age." Virginia's Attorney General, a Baliles also talked about education, candidate for the Democratic guber- which he sees as a "foundation for a natorial slot, said Saturday he thinks New Dominion." the federal government shouldn't "Education is a lifelong process. It decide whether or not a state raises the doesn't end with the attainment of a drinking age to 21, but now doesn't see high school diploma or a college any way around it. degree," he said. "I resent the intrusion of the federal "Education is the foundation for government into what should be state economic development." concerns," said^erry Baliles. To further education in Virginia, he Since Congress has already taken lists as one of his priorities the action to cut funds to states that don't establishment of a statewide have a drinking age of 21 it has "put elementary guidance program to give states in the position where they have aid to young students who need it no choice" but to raise the drinking "Where programs have been age established, improvement has been Baliles, in the area for receptions and seen. It's saved that kid from juvenile interviews, said the age would have to delinquency," which could cost the be raised "this year or next year at the state $20,000 if ho is incarcerated, he latest." / said.
    [Show full text]